Company Accounts and Tax Online 15260388 Board of Directors 1.12.24 30.11.25 30.11.25 No description of principal activity false iso4217:GBP xbrli:pure 15260388 2023-11-04 2024-11-30 15260388 2025-11-30 15260388 2024-12-01 2025-11-30 15260388 2024-11-30 15260388 countries:EnglandWales 2024-12-01 2025-11-30 15260388 curr:PoundSterling 2024-12-01 2025-11-30 15260388 uk-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 15260388 uk-bus:Micro-entities 2024-12-01 2025-11-30 15260388 uk-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 15260388 uk-bus:FullAccounts 2024-12-01 2025-11-30 15260388 uk-bus:RegisteredOffice 2024-12-01 2025-11-30 15260388 uk-bus:Director1 2024-12-01 2025-11-30 15260388 uk-bus:Director1 2024-12-01 15260388 uk-bus:Director1 2025-11-30 15260388 core:AfterOneYear 2025-11-30 15260388 core:AfterOneYear 2024-11-30 15260388 core:WithinOneYear 2025-11-30 15260388 core:WithinOneYear 2024-11-30 15260388 core:WithinOneYear 2024-12-01 2025-11-30 15260388 core:AfterOneYear 2025-11-30 15260388 core:AfterOneYear 2024-11-30 15260388 core:AfterOneYear 2024-12-01 2025-11-30 15260388 core:ShareCapital 2025-11-30 15260388 core:ShareCapital 2024-11-30 15260388 core:RevaluationReserve 2025-11-30 15260388 core:RevaluationReserve 2024-11-30 15260388 core:RetainedEarningsAccumulatedLosses 2025-11-30 15260388 core:RetainedEarningsAccumulatedLosses 2024-11-30 15260388 1 2024-12-01 2025-11-30

# LUMINA MEDICAL AESTHETICS LTD

## Company Registration Number:
15260388 (England and Wales)

## Unaudited micro entity accounts for the year ended 30 November 2025

## Period of accounts

## Start date: 01 December 2024

## End date: 30 November 2025

# LUMINA MEDICAL AESTHETICS LTD

## Contents of the Financial Statements

for the Period Ended 30 November 2025

Company Information - 3 |
Profit and Loss Account - 4 |
Balance sheet - 5 |
Footnotes to the Balance Sheet - 7 |

# LUMINA MEDICAL AESTHETICS LTD

## Company Information

for the Period Ended 30 November 2025

Registered office: |  | 10 Portnalls Close Coulsdon England CR5 3DB
Company Registration Number: |  | 15260388 (England and Wales)

# LUMINA MEDICAL AESTHETICS LTD

## Profit and Loss Account

for the Period Ended 30 November 2025

| 2025 £ | 13 months to 30 Nov 2024 £
--- | --- | ---
Turnover | 14,315 | 4,817
Cost of Materials | ( 5,087 ) | ( 4,380 )
Depreciation and Writeoffs | ( 950 ) | ( 720 )
Other charges | ( 9,127 ) | -
Tax on Profit | ( 0 ) | ( 2,789 )
Profit or (Loss) for Period | ( 849 ) | ( 3,072 )

# LUMINA MEDICAL AESTHETICS LTD

## Balance sheet

As at 30 November 2025

| 2025 £ | 13 months to 30 Nov 2024 £
--- | --- | ---
Fixed Assets: | 1,005 | 1,305
Current assets: | 5,842 |
Creditors: amounts falling due within one year: | ( 5,000 ) | ( 5,000 )
Net current assets (liabilities): | 842 | ( 5,000 )
Total assets less current liabilities: | 1,847 | ( 3,695 )
Provision for liabilities: | ( 1,070 ) |
Total net assets (liabilities): | 777 | ( 3,695 )
Capital and reserves: | 777 | ( 3,695 )

# LUMINA MEDICAL AESTHETICS LTD

## Balance sheet continued

For the year ending 30 November 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 25 March 2026
And Signed On Behalf Of The Board By:

Name: Isobel Morley
Status: Director

The notes form part of these financial statements

# LUMINA MEDICAL AESTHETICS LTD

## Footnotes to the Financial Statements

for the Period Ended 30 November 2025

- ## 1. Employee Information

  Average number of employees: 1

# LUMINA MEDICAL AESTHETICS LTD

## Footnotes to the Financial Statements

for the Period Ended 30 November 2025

- ## 2. Off balance sheet disclosure

  No